Innovation Park Basel Area

Innovation Log


The Park Basel Area community is growing – we are delighted to welcome four new startups in April.

With Polyneuron Pharmaceuticals, a spin-off from University of Basel, and the Polish biotech startup Captor Therapeutics, Park Basel Area gains new experts in the field of innovative health-oriented life sciences.

The French biotech startup Algae Natural Switzerland, which aims to contribute to a healthier nutrition with its microalgae, and a recently founded medtech company in stealth mode further expand the startup portfolio.

Algae Natural Switzerland
Algae Natural Switzerland AG provides protein and/or omega-3 rich high-quality microalgae for food and feed applications. The company’s production process for organic microalgae is developed based on a sustainable and circular approach for a successful eco-conception.

Captor Therapeutics
Captor Therapeutics is a Polish biotech company developing drug candidates for the treatment of oncology and chronic inflammation.

Polyneuron Pharmaceuticals
Polyneuron Pharmaceuticals is a spin-off from the University of Basel focusing on the development of a promising new drug class to treat autoimmune disorders.

Medtech company in stealth mode.

Leave a Comment:

«You may also like»

DBE Research Day 2018

Register for the DBE Research Day 2018

On September 5, 2018, the Department of Biomedical Engineering (DBE) is open to the public. Guests,…> Read more
Predemtec at Switzerland Innovation Park Basel Area is focused on research, development and manufacture of innovative diagnostic tests for use in the detection of Alzheimer-related risk factors

Early Diagnosis for Alzheimer’s Disease

Despite all efforts, science has not yet found an effective way to treat Alzheimer's disease. Predemtec…> Read more
Shared Labs

Plug & Play Lab Space for R&D Projects and Startups

Switzerland Innovation Park Basel Area offers fully equipped plug & play labs for early stage life…> Read more